{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:10:27Z","timestamp":1792015827302,"version":"4.4.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"Abstract<\/jats:title>\n \n Introduction:<\/jats:title>\n Anti-Mullerian hormone (AMH) is a key regulator of ovarian folliculogenesis. Obesity, insulin resistance (IR), hyperandrogenism, and gonadotropins have an inconclusive role in the relation and regulation of AMH to polycystic ovarian syndrome (PCOS).<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n PCOS cases (\n n<\/jats:italic>\n = 80) and matched controls (\n n<\/jats:italic>\n = 80) were evaluated with AMH levels and correlated with age, body mass index (BMI), insulin levels, IR, insulin sensitivity (IS), gonadotropins, and androgens.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Women with PCOS had significantly higher levels of AMH than controls (5.79 \u00b1 4.00 ng\/mL in obese cases vs 2.88 \u00b1 2.38 ng\/mL in obese controls,\n P<\/jats:italic>\n = 0.006; 6.59 \u00b1 4.13 ng\/mL in lean cases vs 3.62 \u00b1 2.04 ng\/mL in lean controls,\n P<\/jats:italic>\n < 0.001). AMH levels did not differ significantly amongst cases with respect to hyperandrogenism, BMI, and PCO morphology. However, women with PCOS who had irregular cycles had significantly greater AMH levels than those with regular menstrual cycles (6.27 \u00b1 4.03 ng\/mL vs 2.36 \u00b1 2.02 ng\/mL,\n P<\/jats:italic>\n = 0.031). There was a negative correlation between AMH and BMI in all four groups, but reached significance only in lean PCOS. AMH did not correlate with insulin levels, HOMA-IR, or IS in any of the four groups. In lean PCOS, AMH correlated significantly with DHEAS (\n r<\/jats:italic>\n = 0.424), androstenedione (\n r<\/jats:italic>\n = 0.413), testosterone (\n r<\/jats:italic>\n = 0.502), and SHBG (\n r<\/jats:italic>\n = 0.412). In obese PCOS, AMH associated positively with androstenedione (\n r<\/jats:italic>\n = 0.490) and testosterone (\n r<\/jats:italic>\n = 0.402).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n BMI, IR, and androgens might differentially regulate AMH levels in lean and obese PCOS. AMH levels were higher in the subset of PCOS with irregular menses than in those with regular cycles; thus, higher AMH indicates a more severe disease state in PCOS.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijem.ijem_491_24","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T12:00:37Z","timestamp":1751112037000},"page":"319-324","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Comparative Study of Anti-Mullerian Hormone and its Correlation with Androgens and Insulin Resistance in Lean and Obese Women with Polycystic Ovary Syndrome"],"prefix":"10.4103","volume":"29","author":[{"given":"Sukirti","family":"Misra","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugal V.","family":"Gada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash V.","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin S.","family":"Rahate","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhakti D.","family":"Karde","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premlata K.","family":"Varthakavi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil M.","family":"Bhagwat","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Bai Yamunabai Laxman Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"R1-20250628","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"R2-20250628","first-page":"303","article-title":"Anti-mullerian hormone as a diagnostic marker in women with polycystic ovary syndrome","volume":"3","author":"Shabir","year":"2016","journal-title":"Indian J Obstet Gynecol Res"},{"key":"R3-20250628","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cen.12557","article-title":"Polycystic ovary syndrome and anti-M\u00fcllerian hormone: Role of insulin resistance, androgens, obesity and gonadotrophins","volume":"81","author":"Cassar","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R4-20250628","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/humrep\/den015","article-title":"The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome","volume":"23","author":"Chen","year":"2008","journal-title":"Hum Reprod"},{"key":"R5-20250628","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/IJWH.S393594","article-title":"The relationship between insulin resistance and obesity and serum anti-mullerian hormone level in Chinese women with polycystic ovary syndrome: A retrospective, single-center cohort study","volume":"15","author":"Zhao","year":"2023","journal-title":"Int J Womens Health"},{"key":"R6-20250628","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R7-20250628","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"R9-20250628","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/jhrs.JHRS_2_19","article-title":"Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome","volume":"12","author":"Satyaraddi","year":"2019","journal-title":"J Hum Reprod Sci"},{"key":"R10-20250628","first-page":"33","article-title":"Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome","volume":"40","author":"Nadaraja","year":"2018","journal-title":"Malays J Pathol"},{"key":"R11-20250628","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4183\/aeb.2017.237","article-title":"Antim\u00fcllerian hormone as indicator of ovarian dysfunction","volume":"13","author":"Bothou","year":"2017","journal-title":"Acta Endocrinol (Buchar)"},{"key":"R12-20250628","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00404-013-2833-9","article-title":"Anti-mullerian hormone and insulin resistance in classic phenotype lean PCOS","volume":"288","author":"Caglar","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"R13-20250628","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.3390\/jcm10143192","article-title":"Impact of obesity on anti-mullerian hormone (AMH) Levels in Women of Reproductive Age","volume":"10","author":"Oldfield","year":"2021","journal-title":"J Clin Med"},{"key":"R14-20250628","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4103\/ijem.ijem_421_21","article-title":"Correlation between serum AMH Levels and cardiometabolic indices in PCOS Women","volume":"25","author":"Mitra","year":"2021","journal-title":"Indian J Endocr Metab"},{"key":"R15-20250628","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/09513590.2019.1613640","article-title":"Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes-a cross-sectional study","volume":"35","author":"Gupta","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"R16-20250628","doi-asserted-by":"crossref","first-page":"e210243","DOI":"10.1530\/EC-21-0243","article-title":"Anti-M\u00fcllerian hormone was independently associated with central obesity but not with general obesity in women with PCOS","volume":"11","author":"Zeng","year":"2022","journal-title":"Endocr Connect"},{"key":"R17-20250628","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2009.03614.x","article-title":"Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS)","volume":"72","author":"Park","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R18-20250628","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13104-018-3207-y","article-title":"The correlation between serum AMH and HOMA-IR among PCOS phenotypes","volume":"11","author":"Wiweko","year":"2018","journal-title":"BMC Res Notes"},{"key":"R19-20250628","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3109\/09513590.2014.943719","article-title":"Serum anti-M\u00fcllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China","volume":"30","author":"Tian","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"R20-20250628","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/uog.11202","article-title":"Polycystic ovaries at ultrasound: Normal variant or silent polycystic ovary syndrome?","volume":"40","author":"Catteau-Jonard","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R21-20250628","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2018.03.007","article-title":"Serum AMH levels and insulin resistance in women with PCOS","volume":"224","author":"Sahmay","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R22-20250628","doi-asserted-by":"crossref","first-page":"12507","DOI":"10.3390\/ijms222212507","article-title":"Anti-m\u00fcllerian hormone in pathogenesis, diagnostic and treatment of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R23-20250628","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/jcmm.16205","article-title":"The role of androgen and its related signals in PCOS","volume":"25","author":"Ye","year":"2021","journal-title":"J Cell Mol Med"},{"key":"R24-20250628","doi-asserted-by":"crossref","first-page":"14156","DOI":"10.1038\/s41598-017-14534-2","article-title":"Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome","volume":"7","author":"Deng","year":"2017","journal-title":"Sci Rep"},{"key":"R25-20250628","article-title":"The relationship between anti-mullerian hormone and androgens in healthy women without hyperandrogenemia","volume":"34","author":"\u00c7akmak","year":"2019","journal-title":"Medeniyet Med J"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_491_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:46:29Z","timestamp":1787067989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_491_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_491_24","relation":{},"ISSN":["2230-8210","2230-9500"],"issn-type":[{"value":"2230-8210","type":"print"},{"value":"2230-9500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}